Federation des caisses Desjardins du Quebec’s Black Diamond Therapeutics BDTX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BDTX Stock Details BDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$596	Hold	280	–	–	﹤0.01%	2805
2025 Q4	$680	Hold	280	–	–	﹤0.01%	2709
2025 Q3	$1.06K	Hold	280	–	–	﹤0.01%	2668
2025 Q2	$694	Hold	280	–	–	﹤0.01%	2541
2025 Q1	$434	Hold	280	–	–	﹤0.01%	2510
2024 Q4	$599	Hold	280	–	–	﹤0.01%	2375
2024 Q3	$1.22K	Hold	280	–	–	﹤0.01%	2295
2024 Q2	$1.3K	Hold	280	–	–	﹤0.01%	2160
2024 Q1	$1.42K	Hold	280	–	–	﹤0.01%	2158
2023 Q4	$787	Hold	280	–	–	﹤0.01%	2166
2023 Q3	$804	Hold	280	–	–	﹤0.01%	2173
2023 Q2	$1.41K	Hold	280	–	–	﹤0.01%	2106
2023 Q1	$529	Hold	280	–	–	﹤0.01%	2207
2022 Q4	$504	Hold	280	–	–	﹤0.01%	2351
2022 Q3	$473	Hold	280	–	–	﹤0.01%	2402
2022 Q2	$689	Hold	280	–	–	﹤0.01%	2421
2022 Q1	$776	Hold	280	–	–	﹤0.01%	2452
2021 Q4	$1.49K	Hold	280	–	–	﹤0.01%	2385
2021 Q3	$2.37K	Hold	280	–	–	﹤0.01%	2390
2021 Q2	$3.41K	Hold	280	–	–	﹤0.01%	2336
2021 Q1	$6.79K	Buy	+280	New	+$7.55K	﹤0.01%	2108

Other funds holding BDTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BDTX Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Black Diamond Therapeutics (BDTX) position steady in Q1 2026 at 280 shares worth $596. The position accounts for ﹤0.01% of the portfolio, ranked #2805.

Federation des caisses Desjardins du Quebec first reported a position in BDTX in Q1 2021 and has held it in 21 quarters since. The position peaked at $6.79K in Q1 2021. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

Federation des caisses Desjardins du Quebec held 280 shares of Black Diamond Therapeutics worth $596 as of Q1 2026.
Federation des caisses Desjardins du Quebec left its Black Diamond Therapeutics share count unchanged in Q1 2026.
Black Diamond Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2805 holding.
Federation des caisses Desjardins du Quebec first reported a position in Black Diamond Therapeutics in Q1 2021 and has held it in 21 quarters since.
Federation des caisses Desjardins du Quebec's Black Diamond Therapeutics position peaked at $6.79K in Q1 2021.
104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.